(Q38104674)

28 August 2017

title

Preclinical models used for immunogenicity prediction of therapeutic proteins (English)

1 reference

28 August 2017

8

Wim Jiskoot

1 reference

28 August 2017

Vera Brinks

1

1 reference

28 August 2017

Daniel Weinbuch

2

1 reference

28 August 2017

Matthew Baker

3

1 reference

28 August 2017

Yann Dean

4

1 reference

28 August 2017

Philippe Stas

5

1 reference

28 August 2017

Stefan Kostense

6

1 reference

28 August 2017

Bonita Rup

7

1 reference

28 August 2017

publication date

7 May 2013

1 reference

28 August 2017

number of pages

10

1 reference

inferred from page(s)

published in

Pharmaceutical Research

1 reference

28 August 2017

volume

30

1 reference

28 August 2017

issue

7

1 reference

28 August 2017

page(s)

1719-1728

1 reference

Mechanisms of adverse drug reactions to biologics

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Immunologic mechanisms of EPO-associated pure red cell aplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Epoetin-associated pure red cell aplasia: past, present, and future considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Immunogenicity of therapeutic proteins: the use of animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Prediction of immunogenicity of therapeutic proteins: validity of computational tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

How to predict and prevent the immunogenicity of therapeutic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Factors influencing the immunogenicity of therapeutic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

New approaches to prediction of immune responses to therapeutic proteins during preclinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Immunogenicity of protein therapeutics: The key causes, consequences and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Discovery of promiscuous HLA-II-restricted T cell epitopes with TEPITOPE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

An interactive Web site providing major histocompatibility ligand predictions: application to HIV research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

SVMHC: a server for prediction of MHC-binding peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Immunogenicity screening in protein drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Application of machine learning techniques in predicting MHC binders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

State of the art and challenges in sequence based T-cell epitope prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Identification of novel consensus CD4 T-cell epitopes from clade B HIV-1 whole genome that are frequently recognized by HIV-1 infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Mapping of the immunodominant T cell epitopes of the protein topoisomerase I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

T-cell epitope mapping using the ELISPOT approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

The ELISPOT assay: an easily transferable method for measuring cellular responses and identifying T cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

T cell recognition of the A2 domain of coagulation factor VIII in hemophilia patients and healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

T cell independent antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Benchmarking B cell epitope prediction: underperformance of existing methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Towards a consensus on datasets and evaluation metrics for developing B-cell epitope prediction tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Immune responses to therapeutic proteins in humans--clinical significance, assessment and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Immunogenic properties of structurally modified human tissue plasminogen activators in chimpanzees and mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Oxidized and aggregated recombinant human interferon beta is immunogenic in human interferon beta transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Induction of immune tolerance by neonatal intravenous injection of human factor VIII in murine hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Induction of factor VIII-specific unresponsiveness by intrathymic factor VIII injection in murine hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Development of a human adaptive immune system in cord blood cell-transplanted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Therapeutic antibodies for autoimmunity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Have we overestimated the benefit of human(ized) antibodies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Can we prevent immunogenicity of human protein drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Humanized mice for immune system investigation: progress, promise and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Antibody Response to Aggregated Human Interferon Alpha2b in Wild-type and Transgenic Immune Tolerant Mice Depends on Type and Level of Aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1062-Z

Immunological substance testing on human lymphatic micro-organoids in vitro

21 January 2018

1 reference

12 December 2020

Transgenic mice as a model to test the immunogenicity of proteins altered by site-specific mutagenesis

1 reference

12 December 2020

Interferon-beta (INF-beta) antibodies in interferon-beta1a- and interferon-beta1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo

1 reference

12 December 2020

Hybrid transgenic immune tolerant mouse model for assessing the breaking of B cell tolerance by human interferon beta

1 reference

12 December 2020

Immunogenicity comparison of interferon beta-1a preparations using the BALB/c mouse model: assessment of a new formulation for use in multiple sclerosis.

1 reference

12 December 2020

Immunogenicity of interferon beta: differences among products

1 reference

12 December 2020

The potential immunogenicity of human insulin and insulin analogues evaluated in a transgenic mouse model

1 reference

12 December 2020

Immunogenicity of different stressed IgG monoclonal antibody formulations in immune tolerant transgenic mice

1 reference

12 December 2020

A novel predictive technique for the MHC class II peptide-binding interaction

1 reference

12 December 2020

The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice)

1 reference

12 December 2020

Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-alpha) in normal and transgenic mice

1 reference

12 December 2020

HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice

1 reference

12 December 2020

Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study

1 reference

12 December 2020

The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD

1 reference

12 December 2020

Immunogenicity of biosynthetic human LysPro insulin compared to native-sequence human and purified porcine insulins in rhesus monkeys immunized over a 6-week period

1 reference

12 December 2020

Strategies for preclinical immunogenicity assessment of protein therapeutics

1 reference

12 December 2020

Anchor profiles of HLA-specific peptides: analysis by a novel affinity scoring method and experimental validation

1 reference

12 December 2020

De-immunization of therapeutic proteins by T-cell epitope modification.

1 reference

12 December 2020

Considerations for optimization and validation of an in vitro PBMC derived T cell assay for immunogenicity prediction of biotherapeutics

1 reference

12 December 2020

HLA-DQ8 transgenic mice lacking endogenous class II molecules respond to house dust allergens: identification of antigenic epitopes

1 reference

12 December 2020

Immunogenicity of recombinant human interleukin-3

1 reference

12 December 2020

Two cases of pure red-cell aplasia due to anti-erythropoietin antibodies

1 reference

12 December 2020

B-Pred, a structure based B-cell epitopes prediction server

1 reference

12 December 2020

Comparison of the immunogenicity of recombinant and pituitary human growth hormone in rhesus monkeys

1 reference

12 December 2020

Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule

1 reference

12 December 2020

Visualizing antigen specific CD4+ T cells using MHC class II tetramers

1 reference

12 December 2020

Immunological mechanism underlying the immune response to recombinant human protein therapeutics

1 reference

12 December 2020

Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation

1 reference

12 December 2020

In silico prediction of peptides binding to multiple HLA-DR molecules accurately identifies immunodominant epitopes from gp43 of Paracoccidioides brasiliensis frequently recognized in primary peripheral blood mononuclear cell responses from sensitiz

1 reference

12 December 2020

Identification of paramyosin T cell epitopes associated with human resistance to Schistosoma mansoni reinfection.

1 reference

12 December 2020

In vivo characterization of sustained-release formulations of human growth hormone.

1 reference

12 December 2020

10.1007/S11095-013-1062-Z

Identifiers

DOI

1 reference

28 August 2017

1 reference